Table 1. Antifungal activities of titled compounds at 200 µg·mL−1 in vitro.
Compounds | Inhibitory (%) | |||||
---|---|---|---|---|---|---|
B. cinerea | C. lagenarium | Py. oryzae | Ph. piricola | R.solani | S.sclerotiorum | |
2a | 66.14 | 44.67 | 70.19 | 68.82 | 78.6 | 44.13 |
2b | 74.17 | 57.50 | 76.81 | 90.25 | 81.58 | 44.65 |
2c | 86.65 | 64.36 | 76.80 | 100 | 93.56 | 37.33 |
2d | 100 | 88.85 | 100 | 100 | 100 | 94.42 |
2e | 65.72 | 58.83 | 49.74 | 92.01 | 51.14 | 90.18 |
2f | 79.49 | 50.91 | 84.74 | 100 | 86.84 | 39.18 |
2g | 92.84 | 66.20 | 81.20 | 100 | 98.51 | 62.35 |
2h | 93.68 | 56.00 | 88.26 | 100 | 51.83 | 100 |
2i | 79.07 | 50.91 | 58.77 | 90.00 | 66.59 | 100 |
2j | 66.98 | 48.65 | 47.76 | 79.41 | 73.80 | 55.26 |
2k | 90.33 | 52.04 | 47.37 | 92.52 | 71.73 | 45.83 |
2l | 80.33 | 67.89 | 67.43 | 100 | 58.70 | 100 |
2-Ua) | 64.83 | 45.16 | 53.46 | 73.15 | 68.67 | 48.62 |
3a | 51.12 | 54.87 | 50.52 | 70.83 | 60.41 | 100 |
3b | 41.94 | 42.98 | 49.34 | 71.34 | 53.21 | 32.43 |
3c | 76.98 | 48.65 | 54.45 | 76.89 | 88.22 | 75.05 |
3d | 100 | 71.30 | 100 | 100 | 73.80 | 100 |
3e | 45.22 | 51.66 | 48.79 | 67.83 | 57.32 | 72.77 |
3f | 29.84 | 48.65 | 30.47 | 41.60 | 63.15 | 68.14 |
3g | 27.75 | 50.34 | 23.78 | 55.71 | 65.55 | 91.66 |
3h | 84.35 | 60.43 | 76.53 | 86.36 | 49.70 | 100 |
3i | 55.29 | 48.08 | 48.95 | 80.93 | 31.71 | 86.91 |
3j | 64.47 | 58.26 | 48.95 | 77.90 | 68.31 | 67.18 |
3k | 43.61 | 61.67 | 52.10 | 73.35 | 40.50 | 92.86 |
3l | 74.64 | 66.82 | 60.28 | 90.07 | 54.45 | 100 |
3-Ub) | 52.50 | 47.16 | 44.67 | 61.64 | 48.70 | 72.75 |
Cuminaldehyde | 83.66 | 42.41 | 65.46 | 100 | 70.02 | 68.87 |
Thiabendazole | 100 | 90.54 | 81.98 | 100 | 100 | 73.95 |
Azoxystrobin | 88.63 | 70.16 | 83.16 | 75.87 | 72.42 | 95.60 |
a) Unsubstituted isoxazoline derivatives. b) Unsubstituted pyrazoline drivatives.